Caption Management, LLC Neurocrine Biosciences Inc Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

A detailed history of Caption Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Caption Management, LLC holds 40,100 shares of NBIX stock, worth $5.43 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

40,100

Previous 15,000 167.33%

Holding current value

$5.43 Million

Previous $2.07 Million 123.54%

% of portfolio

0.08%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $5.24 Million - $7 Million	-45,700 Reduced 94.03%	2,900 $333,000
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $3.72 Million - $4.07 Million	28,400 Added 140.59%	48,600 $6.69 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $2.63 Million - $2.9 Million	20,200 New	20,200 $2.79 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $805,770 - $943,830	9,000 New	9,000 $848,000
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $634,806 - $830,725	8,762 Added 71.6%	21,000 $1.97 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $923,462 - $1.23 Million	-11,594 Reduced 48.65%	12,238 $1.04 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $1.83 Million - $2.11 Million	21,260 Added 826.59%	23,832 $2.29 Million
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $361,028 - $412,863	-4,037 Reduced 61.08%	2,572 $250,000
Q1 2021 May 17, 2021	SELL	$87.57 - $119.4 $822,369 - $1.12 Million	-9,391 Reduced 58.69%	6,609 $643,000
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $425,859 - $530,817	-4,900 Reduced 23.44%	16,000 $1.53 Million
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $2.79 Million - $3.92 Million	-28,989 Reduced 58.11%	20,900 $2.01 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $935,054 - $1.43 Million	10,989 Added 28.25%	49,889 $6.09 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $1.78 Million - $2.7 Million	23,700 Added 155.92%	38,900 $3.37 Million
Q4 2019 Feb 13, 2020	SELL	$86.8 - $118.57 $850,640 - $1.16 Million	-9,800 Reduced 39.2%	15,200 $1.63 Million
Q1 2019 May 14, 2019	BUY	$69.31 - $91.53 $1.73 Million - $2.29 Million	25,000 New	25,000 $2.2 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account

Caption Management, LLC Neurocrine Biosciences Inc Transaction History